Analysts meticulously research for up to 3-4 months to put together one suite of reports, a MedSuite, which is a comprehensive analysis of a group of healthcare markets. This MedCore is one portion of that analysis that focuses on the Neurovascular Balloon Occlusion market segment and provides detailed analysis on the Market Size, Unit Sales, ASPs, and Company Market Shares.
Neurovascular Balloon Occlusion Market Insights
The neurovascular balloon occlusion market has shrunk considerably over the last few years, due to a combination of factors. A 2016 publication found that stent-assisted coiling achieved better complete occlusion rates of aneurysms at six months or later after the procedure, compared to balloon-assisted coiling. In the year prior, it was discovered that these devices could rupture when put in contact with certain liquid embolic glues.
In the United States, there is an active trend towards stent-assisted coiling as opposed to balloon-assisted coiling. The situation for balloon occlusion devices becomes more dire as the U.S. has been quick to adopt other competing technologies for aneurysm embolization.
Neurovascular Balloon Occlusion Market Insights
The neurovascular balloon occlusion market has shrunk considerably over the last few years, due to a combination of factors. A 2016 publication found that stent-assisted coiling achieved better complete occlusion rates of aneurysms at six months or later after the procedure, compared to balloon-assisted coiling. In the year prior, it was discovered that these devices could rupture when put in contact with certain liquid embolic glues.
In the United States, there is an active trend towards stent-assisted coiling as opposed to balloon-assisted coiling. The situation for balloon occlusion devices becomes more dire as the U.S. has been quick to adopt other competing technologies for aneurysm embolization.
